nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—ADRA1D—polycystic ovary syndrome	0.374	0.412	CbGaD
Midodrine—ADRA1B—polycystic ovary syndrome	0.319	0.351	CbGaD
Midodrine—ADRA1A—polycystic ovary syndrome	0.215	0.237	CbGaD
Midodrine—Methoxamine—ADRA1D—polycystic ovary syndrome	0.00205	0.256	CrCbGaD
Midodrine—Methoxamine—ADRA1B—polycystic ovary syndrome	0.00175	0.219	CrCbGaD
Midodrine—Agomelatine—MTNR1B—polycystic ovary syndrome	0.00162	0.203	CrCbGaD
Midodrine—Methoxamine—ADRA1A—polycystic ovary syndrome	0.00118	0.147	CrCbGaD
Midodrine—Melatonin—MTNR1B—polycystic ovary syndrome	0.000949	0.119	CrCbGaD
Midodrine—Melatonin—CYP19A1—polycystic ovary syndrome	0.000258	0.0323	CrCbGaD
Midodrine—Melatonin—CYP1A1—polycystic ovary syndrome	0.00019	0.0237	CrCbGaD
Midodrine—Heartburn—Metformin—polycystic ovary syndrome	0.000188	0.129	CcSEcCtD
Midodrine—Abdominal discomfort—Metformin—polycystic ovary syndrome	7.76e-05	0.0532	CcSEcCtD
Midodrine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	6.83e-05	0.0468	CcSEcCtD
Midodrine—Bradycardia—Metformin—polycystic ovary syndrome	6.6e-05	0.0452	CcSEcCtD
Midodrine—Flushing—Metformin—polycystic ovary syndrome	6.02e-05	0.0412	CcSEcCtD
Midodrine—Cardiac disorder—Metformin—polycystic ovary syndrome	6.02e-05	0.0412	CcSEcCtD
Midodrine—Angiopathy—Metformin—polycystic ovary syndrome	5.88e-05	0.0403	CcSEcCtD
Midodrine—Chills—Metformin—polycystic ovary syndrome	5.82e-05	0.0399	CcSEcCtD
Midodrine—Flatulence—Metformin—polycystic ovary syndrome	5.56e-05	0.0381	CcSEcCtD
Midodrine—Muscle spasms—Metformin—polycystic ovary syndrome	5.43e-05	0.0372	CcSEcCtD
Midodrine—Hypertension—Metformin—polycystic ovary syndrome	4.87e-05	0.0334	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	4.77e-05	0.0327	CcSEcCtD
Midodrine—ADRA1D—Signaling by GPCR—LHB—polycystic ovary syndrome	4.71e-05	0.000568	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—GNAS—polycystic ovary syndrome	4.65e-05	0.000561	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	4.64e-05	0.000559	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GNRH1—polycystic ovary syndrome	4.6e-05	0.000555	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	4.53e-05	0.000546	CbGpPWpGaD
Midodrine—Nervous system disorder—Metformin—polycystic ovary syndrome	4.52e-05	0.031	CcSEcCtD
Midodrine—ADRA1B—Signaling by GPCR—FSHR—polycystic ovary syndrome	4.49e-05	0.000542	CbGpPWpGaD
Midodrine—Skin disorder—Metformin—polycystic ovary syndrome	4.47e-05	0.0307	CcSEcCtD
Midodrine—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	4.47e-05	0.000539	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	4.42e-05	0.000533	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—SCT—polycystic ovary syndrome	4.41e-05	0.000532	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	4.39e-05	0.00053	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	4.38e-05	0.000529	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.37e-05	0.000527	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.37e-05	0.000527	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.36e-05	0.000526	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	4.34e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	4.3e-05	0.000519	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.21e-05	0.000508	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.21e-05	0.000508	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.16e-05	0.000502	CbGpPWpGaD
Midodrine—Paraesthesia—Metformin—polycystic ovary syndrome	4.14e-05	0.0283	CcSEcCtD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.11e-05	0.000496	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	4.11e-05	0.000496	CbGpPWpGaD
Midodrine—Dyspnoea—Metformin—polycystic ovary syndrome	4.11e-05	0.0281	CcSEcCtD
Midodrine—Somnolence—Metformin—polycystic ovary syndrome	4.09e-05	0.0281	CcSEcCtD
Midodrine—ADRA1D—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.09e-05	0.000493	CbGpPWpGaD
Midodrine—Dyspepsia—Metformin—polycystic ovary syndrome	4.05e-05	0.0278	CcSEcCtD
Midodrine—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.03e-05	0.000487	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	3.99e-05	0.000482	CbGpPWpGaD
Midodrine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	3.98e-05	0.0273	CcSEcCtD
Midodrine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.97e-05	0.000479	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.96e-05	0.000477	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.93e-05	0.000474	CbGpPWpGaD
Midodrine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.92e-05	0.000473	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	3.91e-05	0.000472	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	3.87e-05	0.000467	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.86e-05	0.000466	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	3.86e-05	0.000466	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.86e-05	0.000466	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.85e-05	0.000464	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	3.82e-05	0.000461	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.82e-05	0.000461	CbGpPWpGaD
Midodrine—Feeling abnormal—Metformin—polycystic ovary syndrome	3.8e-05	0.026	CcSEcCtD
Midodrine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	3.77e-05	0.0258	CcSEcCtD
Midodrine—ADRA1D—Signaling Pathways—INHBB—polycystic ovary syndrome	3.76e-05	0.000454	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	3.74e-05	0.000451	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	3.7e-05	0.000446	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	3.66e-05	0.000442	CbGpPWpGaD
Midodrine—Abdominal pain—Metformin—polycystic ovary syndrome	3.64e-05	0.025	CcSEcCtD
Midodrine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.63e-05	0.000438	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.63e-05	0.000438	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	3.58e-05	0.000432	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.51e-05	0.000424	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.51e-05	0.000424	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	3.5e-05	0.000422	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.49e-05	0.000422	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.49e-05	0.000421	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.47e-05	0.000419	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.43e-05	0.000414	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.42e-05	0.000413	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.42e-05	0.000412	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.41e-05	0.000412	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.39e-05	0.000409	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.39e-05	0.000409	CbGpPWpGaD
Midodrine—Asthenia—Metformin—polycystic ovary syndrome	3.3e-05	0.0226	CcSEcCtD
Midodrine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.29e-05	0.000397	CbGpPWpGaD
Midodrine—Pruritus—Metformin—polycystic ovary syndrome	3.26e-05	0.0223	CcSEcCtD
Midodrine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	3.25e-05	0.000393	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.22e-05	0.000389	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.22e-05	0.000389	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FSHR—polycystic ovary syndrome	3.2e-05	0.000386	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.2e-05	0.000386	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.2e-05	0.000386	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—POMC—polycystic ovary syndrome	3.13e-05	0.000378	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	3.12e-05	0.000377	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.11e-05	0.000375	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.1e-05	0.000374	CbGpPWpGaD
Midodrine—Dizziness—Metformin—polycystic ovary syndrome	3.05e-05	0.0209	CcSEcCtD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.03e-05	0.000366	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.01e-05	0.000364	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.01e-05	0.000363	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	2.97e-05	0.000359	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	2.96e-05	0.000357	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.92e-05	0.000353	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.92e-05	0.000353	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.91e-05	0.000352	CbGpPWpGaD
Midodrine—Rash—Metformin—polycystic ovary syndrome	2.9e-05	0.0199	CcSEcCtD
Midodrine—Dermatitis—Metformin—polycystic ovary syndrome	2.9e-05	0.0199	CcSEcCtD
Midodrine—Headache—Metformin—polycystic ovary syndrome	2.89e-05	0.0198	CcSEcCtD
Midodrine—ADRA1D—Signaling Pathways—FST—polycystic ovary syndrome	2.85e-05	0.000344	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.85e-05	0.000343	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.84e-05	0.000343	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.83e-05	0.000342	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.82e-05	0.00034	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LHB—polycystic ovary syndrome	2.78e-05	0.000336	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.77e-05	0.000335	CbGpPWpGaD
Midodrine—Nausea—Metformin—polycystic ovary syndrome	2.74e-05	0.0188	CcSEcCtD
Midodrine—ADRA1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.72e-05	0.000328	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.65e-05	0.00032	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.63e-05	0.000318	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.63e-05	0.000317	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SCT—polycystic ovary syndrome	2.61e-05	0.000315	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.6e-05	0.000314	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.59e-05	0.000312	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.58e-05	0.000311	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.57e-05	0.000311	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	2.53e-05	0.000305	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	2.53e-05	0.000305	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.52e-05	0.000305	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.5e-05	0.000301	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.49e-05	0.0003	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF18—polycystic ovary syndrome	2.44e-05	0.000295	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.43e-05	0.000293	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RBP4—polycystic ovary syndrome	2.42e-05	0.000292	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.41e-05	0.000291	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.39e-05	0.000288	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.37e-05	0.000285	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.36e-05	0.000284	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.35e-05	0.000284	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.34e-05	0.000282	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.31e-05	0.000279	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.31e-05	0.000279	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.29e-05	0.000277	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—YAP1—polycystic ovary syndrome	2.26e-05	0.000273	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.26e-05	0.000272	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GAB1—polycystic ovary syndrome	2.23e-05	0.000269	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.22e-05	0.000267	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.19e-05	0.000264	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.18e-05	0.000263	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.16e-05	0.000261	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.14e-05	0.000258	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INSR—polycystic ovary syndrome	2.13e-05	0.000257	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.12e-05	0.000256	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.1e-05	0.000254	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.09e-05	0.000252	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.08e-05	0.00025	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.06e-05	0.000249	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.05e-05	0.000247	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.03e-05	0.000245	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.03e-05	0.000245	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.01e-05	0.000243	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.01e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2e-05	0.000241	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.98e-05	0.000239	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	1.98e-05	0.000238	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.94e-05	0.000234	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.94e-05	0.000234	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.92e-05	0.000232	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.92e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.9e-05	0.000229	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.88e-05	0.000227	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.85e-05	0.000223	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	1.84e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	1.84e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.83e-05	0.000221	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.8e-05	0.000217	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.79e-05	0.000216	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.78e-05	0.000215	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.77e-05	0.000214	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.77e-05	0.000213	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.76e-05	0.000212	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.75e-05	0.000211	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.71e-05	0.000206	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.71e-05	0.000206	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.7e-05	0.000205	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.68e-05	0.000203	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.67e-05	0.000201	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.66e-05	0.0002	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.65e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.64e-05	0.000198	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.63e-05	0.000196	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.62e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.61e-05	0.000194	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.6e-05	0.000193	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.57e-05	0.00019	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.54e-05	0.000186	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.52e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.52e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.52e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.49e-05	0.00018	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.49e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.47e-05	0.000178	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.47e-05	0.000177	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.46e-05	0.000176	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.45e-05	0.000175	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.45e-05	0.000175	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.42e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.41e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.41e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.41e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.35e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.35e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.34e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.34e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.33e-05	0.000161	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.33e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	1.32e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.3e-05	0.000157	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.29e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.29e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.28e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.26e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.26e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.25e-05	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.25e-05	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.21e-05	0.000146	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.19e-05	0.000144	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.18e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.18e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.17e-05	0.000141	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.16e-05	0.00014	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.15e-05	0.000138	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.14e-05	0.000137	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	1.13e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.12e-05	0.000135	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.11e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	1.1e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.09e-05	0.000132	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.08e-05	0.000131	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.07e-05	0.000129	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.04e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.9e-06	0.000119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	9.86e-06	0.000119	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.72e-06	0.000117	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	9.49e-06	0.000115	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	9.44e-06	0.000114	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	9.37e-06	0.000113	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.22e-06	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	9.17e-06	0.000111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	9.13e-06	0.00011	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	9.12e-06	0.00011	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.97e-06	0.000108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.67e-06	0.000105	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.43e-06	0.000102	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.32e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	8.18e-06	9.87e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.15e-06	9.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	7.88e-06	9.51e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	7.83e-06	9.45e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	7.58e-06	9.14e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	7.57e-06	9.14e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.53e-06	9.08e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.27e-06	8.77e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.2e-06	8.68e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.17e-06	8.65e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	7e-06	8.44e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	6.98e-06	8.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	6.96e-06	8.4e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.8e-06	8.2e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.73e-06	8.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.73e-06	8.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.39e-06	7.71e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.34e-06	7.64e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.96e-06	7.2e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.8e-06	6.99e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.15e-06	6.21e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.14e-06	6.2e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.07e-06	6.11e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.04e-06	6.08e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.95e-06	5.97e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.4e-06	5.3e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	4.12e-06	4.98e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.42e-06	4.13e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.04e-06	3.67e-05	CbGpPWpGaD
